Trelstar

Trelstar is a brand name for the drug Triptorelin, a gonadotropin-releasing hormone (GnRH) agonist used in the treatment of hormone-responsive cancers such as prostate cancer and breast cancer, and in the management of endometriosis. It is produced by Watson Pharmaceuticals, now a part of Allergan.

Pharmacology[edit | edit source]

Triptorelin, the active ingredient in Trelstar, is a decapeptide (a peptide composed of ten amino acids) that acts as a gonadotropin-releasing hormone (GnRH) agonist. It works by decreasing the production of certain hormones in the body, which helps to slow or stop the growth of cancer cells and endometriosis.

Uses[edit | edit source]

Trelstar is used in the treatment of hormone-responsive cancers such as prostate cancer and breast cancer, and in the management of endometriosis. It is also used in the treatment of precocious puberty (early puberty) in children.

Side Effects[edit | edit source]

Common side effects of Trelstar include hot flashes, decreased sexual desire or ability, tiredness, nausea, diarrhea, constipation, vomiting, and sweating. Serious side effects can include bone pain, inability to move, and symptoms of a pituitary gland problem.

Dosage[edit | edit source]

Trelstar is administered by injection into a muscle by a healthcare professional, usually once every 4, 12, or 24 weeks or as directed by the doctor. The dosage is based on the patient's medical condition and response to treatment.